Reply | Published:

Evidence for traditional Chinese medication to treat cardiovascular disease

Nature Reviews Cardiology volume 12, page 374 (2015) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Integrating traditional Chinese medicine into Western cardiovascular medicine: an evidence-based approach. Nat. Rev. Cardiol. .

  2. 2.

    et al. Traditional Chinese medication for cardiovascular disease. Nat. Rev. Cardiol. 12, 115–122 (2015).

  3. 3.

    et al. Prospective multicenter clinical trial of Chinese herbal formula JZQG (Jiangzhuoqinggan) for hypertension. Am. J. Chin. Med. 41, 33–42 (2013).

  4. 4.

    et al. Cardioankle vascular index evaluations revealed that cotreatment of ARB antihypertension medication with traditional Chinese medicine improved arterial functionality. J. Cardiovasc. Pharmacol. 61, 355–360 (2013).

  5. 5.

    et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am. J. Cardiol. 101, 1689–1693 (2008).

  6. 6.

    et al. Qi-Shen-Yi-Qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid. Based Complement. Alternat. Med. 2013, 738391 (2013).

  7. 7.

    et al. Combination of Chinese herbal medicines and conventional treatment versus conventional treatment alone in patients with acute coronary syndrome after percutaneous coronary intervention (5C Trial): an open-label randomized controlled, multicenter study. Evid. Based Complement. Alternat. Med. 2013, 741518 (2013).

  8. 8.

    et al. Clinical analysis of Jingzhiguanxin tablet for the treatment of 112 cases of patients with angina pectoris: a randomized, double-blind, placebo-controlled trial [Chinese]. Chin. J. Cardiol. 10, 85–89 (1982).

  9. 9.

    , , & Effect of Tianma Gouteng decoction on the curative efficacy and quality of life in patients with essential hypertension [Chinese]. Chin. J. Clin. Rehabil. 8, 2880–2881 (2004).

  10. 10.

    The clinical observation on a combined treatment of hypertension with traditional Chinese medicine and Western medicine, a report of 50 cases [Chinese]. Shanxi J. Trad. Chin. Med. 24, 27–28 (2008).

  11. 11.

    , , & The effects of erbai jiangya decoction on essential hypertension [Chinese]. J. N. Chin. Med. 44, 14–15 (2012).

  12. 12.

    The clinical observation on the therapy enriching Yin and suppressing Yang for senile hypertension [Chinese]. J. Emerg. Trad. Chin. Med. 16, 518–519 (2007).

  13. 13.

    The effects of decoctions of Pinellia ternata plus Atractylodes macrocephala rhizome, tall gastrodia plus Alisma spp. on body-mass index and depressurization of patients with hypertension, type of accumulation of Phlegm-Damp in TCM [Chinese]. J. Emerg. Trad. Chin. Med. 16, 650–651 (2007).

  14. 14.

    The effectiveness of a combination of traditional Chinese medicine with Western medicine in patients with essential hypertension [Chinese]. Trad. Chin. Med. Res. 25, 15–17 (2012).

  15. 15.

    , , & A clinical study of the effect of sini decoction on essential hypertension with Yang deficiency [Chinese]. Liaoning J. Trad. Chin. Med. 40, 2480–2482 (2013).

  16. 16.

    , , , & The effects of compound qima capsules on isolated systolic hypertension [Chinese]. J. Guangzhou Univ. Trad. Chin. Med. 27, 217–221 (2010).

  17. 17.

    The effects of the decoction of tall gastrodia and Uncaria tomentosa on essential hypertension [Chinese]. Chin. J. Exp. Trad. Med. Formulae 17, 252–253 (2011).

  18. 18.

    et al. Effects of the decoction of tall gastrodia and Uncaria tomentosa on serum SOD and MDA of patients with hypertension in the pattern of ascendant liver Yang [Chinese]. Household Med. J. 21, 321–322 (2005).

  19. 19.

    , , & Effects of traditional Chinese patent medicine on essential hypertension: a systematic review. Medicine (Baltimore) 94, e442 (2015).

Download references

Author information

Affiliations

  1. The Key Laboratory of Cardiovascular Remodelling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Shandong University, 107 Wen Hua Xi Road, Jinan, Shandong 250012, China.

    • Pan-Pan Hao
    • , Fan Jiang
    • , Yu-Guo Chen
    • , Jianmin Yang
    • , Kai Zhang
    • , Ming-Xiang Zhang
    • , Cheng Zhang
    • , Yu-Xia Zhao
    •  & Yun Zhang

Authors

  1. Search for Pan-Pan Hao in:

  2. Search for Fan Jiang in:

  3. Search for Yu-Guo Chen in:

  4. Search for Jianmin Yang in:

  5. Search for Kai Zhang in:

  6. Search for Ming-Xiang Zhang in:

  7. Search for Cheng Zhang in:

  8. Search for Yu-Xia Zhao in:

  9. Search for Yun Zhang in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Yu-Xia Zhao.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrcardio.2014.177-c2

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing